Pharmesis International Balance Sheet Health
Financial Health criteria checks 3/6
Pharmesis International has a total shareholder equity of CN¥54.2M and total debt of CN¥15.0M, which brings its debt-to-equity ratio to 27.7%. Its total assets and total liabilities are CN¥85.9M and CN¥31.7M respectively.
Key information
27.7%
Debt to equity ratio
CN¥15.00m
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥9.48m |
| Equity | CN¥54.19m |
| Total liabilities | CN¥31.71m |
| Total assets | CN¥85.90m |
Financial Position Analysis
Short Term Liabilities: BFK's short term assets (CN¥33.3M) exceed its short term liabilities (CN¥30.6M).
Long Term Liabilities: BFK's short term assets (CN¥33.3M) exceed its long term liabilities (CN¥1.1M).
Debt to Equity History and Analysis
Debt Level: BFK's net debt to equity ratio (10.2%) is considered satisfactory.
Reducing Debt: BFK's debt to equity ratio has increased from 15.2% to 27.7% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: BFK has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: BFK has less than a year of cash runway if free cash flow continues to reduce at historical rates of 3.3% each year